Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study (Q57180242)
Jump to navigation
Jump to search
scientific article published in The Lancet
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study |
scientific article published in The Lancet |
Statements
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study (English)
Chloe Orkin
Deenan Pillay
Andrew N Phillips
David Dunn
Richard Gilson
Clifford Leen
Alan Wilson
Achim Schwenk
Teresa Hill
Martin Fisher
John Walsh
Loveleen Bansi
Philippa Easterbrook
Margaret Johnson
UK Collaborative HIV Cohort (CHIC) Study
1 December 2007